These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 28488260

  • 1. Cessation of extracorporeal photopheresis in chronic lung allograft dysfunction: effects on clinical outcome in adults.
    Robinson CA, Huber L, Murer C, Schuurmans M, Kohler M, Hofbauer G, Benden C.
    Swiss Med Wkly; 2017; 147():w14429. PubMed ID: 28488260
    [Abstract] [Full Text] [Related]

  • 2. Lung transplant recipients on long-term extracorporeal photopheresis.
    Isenring B, Robinson C, Buergi U, Schuurmans MM, Kohler M, Huber LC, Benden C.
    Clin Transplant; 2017 Oct; 31(10):. PubMed ID: 28653398
    [Abstract] [Full Text] [Related]

  • 3. Phenotyping established chronic lung allograft dysfunction predicts extracorporeal photopheresis response in lung transplant patients.
    Greer M, Dierich M, De Wall C, Suhling H, Rademacher J, Welte T, Haverich A, Warnecke G, Ivanyi P, Buchholz S, Gottlieb J, Fuehner T.
    Am J Transplant; 2013 Apr; 13(4):911-918. PubMed ID: 23406373
    [Abstract] [Full Text] [Related]

  • 4. Early extracorporeal photopheresis treatment is associated with better survival in patients with chronic or recurrent acute lung allograft dysfunction.
    Gautschi F, Vogelmann T, Ortmanns G, Knörr F, Steinack C, Hage R, Nägeli M, Schuurmans MM.
    J Clin Apher; 2024 Jun; 39(3):e22128. PubMed ID: 38829041
    [Abstract] [Full Text] [Related]

  • 5. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review.
    Benden C, Haughton M, Leonard S, Huber LC.
    J Heart Lung Transplant; 2017 Sep; 36(9):921-933. PubMed ID: 28662986
    [Abstract] [Full Text] [Related]

  • 6. Long-Term Off-Line Extracorporeal Photochemotherapy in Patients with Chronic Lung Allograft Rejection Not Responsive to Conventional Treatment: A 10-Year Single-Centre Analysis.
    Del Fante C, Scudeller L, Oggionni T, Viarengo G, Cemmi F, Morosini M, Cascina A, Meloni F, Perotti C.
    Respiration; 2015 Sep; 90(2):118-28. PubMed ID: 26112178
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Extracorporeal photopheresis after lung transplantation: a 10-year single-center experience.
    Benden C, Speich R, Hofbauer GF, Irani S, Eich-Wanger C, Russi EW, Weder W, Boehler A.
    Transplantation; 2008 Dec 15; 86(11):1625-7. PubMed ID: 19077900
    [Abstract] [Full Text] [Related]

  • 9. Extracorporeal photopheresis (ECP) in the treatment of chronic lung allograft dysfunction (CLAD): a prospective, multicentre, open-label, randomised controlled trial studying the addition of ECP to standard care in the treatment of bilateral lung transplant patients with CLAD (E-CLAD UK).
    Fisher AJ, White M, Goudie N, Kershaw A, Phillipson J, Bardgett M, Lally J, Bevin-Nicholls A, Chadwick T, Bryant A, Russell S, Smith H, Frisby L, Errington R, Carby M, Thompson R, Santhanakrishnan K, Parmar J, Lordan JL, Vale L, Hancock H, Exley C, Gennery AR, Wason JM.
    BMJ Open Respir Res; 2024 May 09; 11(1):. PubMed ID: 38724453
    [Abstract] [Full Text] [Related]

  • 10. The efficacy of extracorporeal photopheresis to arrest bronchiolitis obliterans in lung allograft recipients was compared between two automated photopheresis instruments.
    Chionis L, Grossman BJ, Hachem R, Commean P, Derfler MC, Vedantham S, Dodds K, Spitznagel E, Atkinson J, Despotis G.
    Transfusion; 2018 Dec 09; 58(12):2933-2941. PubMed ID: 30312482
    [Abstract] [Full Text] [Related]

  • 11. Effect of extracorporeal photopheresis on lung function decline for severe bronchiolitis obliterans syndrome following allogeneic stem cell transplantation.
    Brownback KR, Simpson SQ, Pitts LR, Polineni D, McGuirk JP, Ganguly S, Aljitawi OS, Lin TL, Singh A, Abhyankar S.
    J Clin Apher; 2016 Aug 09; 31(4):347-52. PubMed ID: 26031713
    [Abstract] [Full Text] [Related]

  • 12. Extracorporeal photopheresis to attenuate decline in lung function due to refractory obstructive allograft dysfunction.
    EPI Study Group, Hage CA, Klesney-Tait J, Wille K, Arcasoy S, Yung G, Hertz M, Chan KM, Morrell M, Goldberg H, Vedantham S, Derfler MC, Commean P, Berman K, Spitznagel E, Atkinson J, Despotis G.
    Transfus Med; 2021 Aug 09; 31(4):292-302. PubMed ID: 33955079
    [Abstract] [Full Text] [Related]

  • 13. The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation.
    Morrell MR, Despotis GJ, Lublin DM, Patterson GA, Trulock EP, Hachem RR.
    J Heart Lung Transplant; 2010 Apr 09; 29(4):424-31. PubMed ID: 19853479
    [Abstract] [Full Text] [Related]

  • 14. Outcomes Following Extracorporeal Photopheresis for Chronic Lung Allograft Dysfunction Following Lung Transplantation: A Single-Center Experience.
    Vazirani J, Routledge D, Snell GI, Watson D, Paraskeva M, Westall GP, Harrison SJ.
    Transplant Proc; 2021 Apr 09; 53(1):296-302. PubMed ID: 33039145
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of extracorporeal photopheresis in clearance of antibodies to donor-specific and lung-specific antigens in lung transplant recipients.
    Baskaran G, Tiriveedhi V, Ramachandran S, Aloush A, Grossman B, Hachem R, Mohanakumar T.
    J Heart Lung Transplant; 2014 Sep 09; 33(9):950-6. PubMed ID: 24906794
    [Abstract] [Full Text] [Related]

  • 16. Comparison of extracorporeal photopheresis and alemtuzumab for the treatment of chronic lung allograft dysfunction.
    Moniodis A, Townsend K, Rabin A, Aloum O, Stempel J, Burkett P, Camp P, Divo M, El-Chemaly S, Mallidi H, Rosas I, Fuhlbrigge A, Koo S, Goldberg HJ.
    J Heart Lung Transplant; 2018 Mar 09; 37(3):340-348. PubMed ID: 28431983
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of Extracorporeal Photopheresis in Patients With Bronchiolitis Obliterans Syndrome After Lung Transplantation.
    Pecoraro Y, Carillo C, Diso D, Mantovani S, Cimino G, De Giacomo T, Troiani P, Shafii M, Gherzi L, Amore D, Rendina EA, Venuta F, Anile M.
    Transplant Proc; 2017 May 09; 49(4):695-698. PubMed ID: 28457374
    [Abstract] [Full Text] [Related]

  • 18. A European Multi-Center Analysis of Extracorporeal Photopheresis as Therapy for Chronic Lung Allograft Dysfunction.
    Benazzo A, Bagnera C, Ius F, Del Fante C, Gottlieb J, Hoetzenecker K, Meloni F, Jaksch P, Greer M.
    Transpl Int; 2023 May 09; 36():11551. PubMed ID: 38282747
    [Abstract] [Full Text] [Related]

  • 19. Extracorporeal Photopheresis for Bronchiolitis Obliterans Syndrome After Lung Transplantation.
    Hachem R, Corris P.
    Transplantation; 2018 Jul 09; 102(7):1059-1065. PubMed ID: 29557913
    [Abstract] [Full Text] [Related]

  • 20. A prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation.
    Jaksch P, Scheed A, Keplinger M, Ernst MB, Dani T, Just U, Nahavandi H, Klepetko W, Knobler R.
    J Heart Lung Transplant; 2012 Sep 09; 31(9):950-7. PubMed ID: 22884382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.